Mawer Investment Management
IHE icon

Mawer Investment Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Mawer Investment Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-22,200
Closed -$1.04M – 105
2018
Q4 		$1.04M Buy
+22,200
New +$1.14M 0.01% 103
2018
Q1 		– Sell
-159,300
Closed -$8.2M – 112
2017
Q4 		$8.2M Buy
+159,300
New +$8.19M 0.07% 96

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Mawer Investment Management's IHE Position: Q1 2019 in Review

Mawer Investment Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2019, closing a stake of 22,200 shares — an estimated $1.04M sold.

Mawer Investment Management first reported a position in IHE in Q4 2017 and held it in 2 quarters. The position peaked at $8.2M in Q4 2017. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2019.

  • Mawer Investment Management reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
  • Mawer Investment Management sold 22,200 iShares US Pharmaceuticals ETF shares in Q1 2019, an estimated $1.04M.
  • Mawer Investment Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2017 and held it in 2 quarters.
  • Mawer Investment Management's iShares US Pharmaceuticals ETF position peaked at $8.2M in Q4 2017.
  • 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2019.

Based on Mawer Investment Management's 13F filing for Q1 2019, filed 9 May 2019.